Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Allison Frisbee | SR VP CORP OPERATIONS LEGAL | 2024-02-21 | 12,105 | $1.05 | $12.76kSell |
Charles Y. Lin | SR VP RESEARCH DEVELOPMENT | 2024-02-21 | 12,036 | $1.05 | $12.69kSell |
Elizabeth A. Olek | SR VP CLINICAL SCIENCE | 2024-02-21 | 7,368 | $1.05 | $7.77kSell |
Barbara Kosacz | COO General Counsel | 2024-01-04 | 10,676 | $1.18 | $12.64kSell |
Jorge Dimartino | Chief Medical Officer VP | 2024-01-04 | 12,009 | $1.18 | $14.22kSell |
Christopher Dinsmore | Chief Scientific Officer | 2024-01-04 | 7,366 | $1.18 | $8.72kSell |
Christopher Dinsmore | Chief Scientific Officer | 2023-12-12 | 10,032 | $1.31 | $13.09kSell |
Jorge Dimartino | Chief Medical Officer VP | 2023-12-12 | 17,367 | $1.31 | $22.66kSell |
Norbert W. Bischofberger | President CEO | 2023-11-17 | 97,935 | $1.08 | $106.16kBuy |
Norbert W. Bischofberger | President CEO | 2023-11-16 | 262,433 | $1.00 | $261.65kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Norbert W. Inger A. Revocable Inter Vivos Trust Bischofberger | 7.27% | 4,370,496 | $5.20M | Insider |
Omega Fund V LP | 6.35% | 3,818,283 | $4.54M | Insider |
Otello Stampacchia | 6.35% | 3,818,283 | $4.54M | Insider |
Omega Fund Management LLC | 6.35% | 3,818,283 | $4.54M | Institution |
Norbert W. Bischofberger | 5.12% | 3,074,754 | $3.66M | Insider |
Arie Belldegrun | 4.98% | 2,994,889 | $3.56M | Insider |
Bvf Inc | 4.83% | 2,905,043 | $3.46M | Institution |
Vida Ventures Advisors LLC | 4.60% | 2,765,314 | $3.29M | Institution |
John C. Martin | 3.25% | 1,952,364 | $2.32M | Insider |
Perceptive Advisors LLC | 2.92% | 1,752,745 | $2.09M | Institution |